AU2002241670A1 - Method for treating glaucoma IB - Google Patents

Method for treating glaucoma IB

Info

Publication number: AU2002241670A1
Authority: AU; Australia
Prior art keywords: treating glaucoma; glaucoma; treating
Prior art date: 2000-12-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002241670A

Other versions

AU2002241670B2 (en

Inventor

Stanley C. Bell

John J. Egan

Martin Gall

Edmond J. Lavoie

Sara Vasan

Dilip Wagle

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Synvista Therapeutics Inc

Original Assignee

Alteon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-29

Filing date

2001-12-28

Publication date

2003-01-23

2001-12-28 Application filed by Alteon Inc filed Critical Alteon Inc

2001-12-28 Priority claimed from PCT/US2001/049550 external-priority patent/WO2002053158A1/en

2003-01-23 Publication of AU2002241670A1 publication Critical patent/AU2002241670A1/en

2006-08-17 Application granted granted Critical

2006-08-17 Publication of AU2002241670B2 publication Critical patent/AU2002241670B2/en

2021-12-28 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US25942600P	2000-12-29	2000-12-29
US60/259,426		2000-12-29
US29625701P	2001-06-06	2001-06-06
US60/296,257		2001-06-06
US30741801P	2001-07-24	2001-07-24
US60/307,418		2001-07-24
PCT/US2001/049550 WO2002053158A1 (en)	2000-12-29	2001-12-28	Method for treating glaucoma ib

Publications (2)

Publication Number	Publication Date
AU2002241670A1 true AU2002241670A1 (en)	2003-01-23
AU2002241670B2 AU2002241670B2 (en)	2006-08-17

Family

ID=27401231

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002241670A Ceased AU2002241670B2 (en)	2000-12-29	2001-12-28	Method for treating glaucoma IB

Country Status (9)

Country	Link
US (1)	US7432254B2 (en)
EP (1)	EP1353669B1 (en)
JP (1)	JP2004520329A (en)
AT (1)	ATE369856T1 (en)
AU (1)	AU2002241670B2 (en)
CA (1)	CA2433346A1 (en)
DE (1)	DE60130030T2 (en)
MX (1)	MXPA03005922A (en)
WO (1)	WO2002053158A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003523388A (en) *	2000-02-23	2003-08-05	アルテオンインコーポレーテッド	Treatment of disorders associated with thiazolium compounds and protein aging
AU8054601A (en) *	2000-07-13	2002-02-05	Alteon Inc	Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disordersassociated with protein aging
US7049333B2 (en)	2002-06-04	2006-05-23	Sanofi-Aventis Deutschland Gmbh	Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
CN100349881C (en) *	2003-04-02	2007-11-21	深圳市东阳光实业发展有限公司	Substituted five-membered azacyclo salt compound and application thereof in treating protein aging related diseases
US20050014747A1 (en) *	2003-04-18	2005-01-20	Emily Reinhard	Dihydrothiazine prodrugs of thiazolium agents
US8101777B2 (en) *	2003-08-26	2012-01-24	Ecole Polytechnique Federale De Lausanne	Ionic liquids based on imidazolium salts incorporating a nitrile functionality
CA2561249A1 (en)	2004-03-31	2005-10-20	Lexicon Genetics, Inc.	2-aminomethylthiazole-5-carboxamides as protein kinase modulators
SG156650A1 (en)	2004-07-16	2009-11-26	Sunesis Pharmaceuticals Inc	Thienopyrimidines useful as aurora kinase inhibitors
US8921406B2 (en)	2005-08-21	2014-12-30	AbbVie Deutschland GmbH & Co. KG	5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors
US10206813B2 (en)	2009-05-18	2019-02-19	Dose Medical Corporation	Implants with controlled drug delivery features and methods of using same
US12478503B2 (en)	2009-05-18	2025-11-25	Glaukos Corporation	Implants with controlled drug delivery features and methods of using same
CA2799468A1 (en)	2010-05-14	2011-11-17	Mallinckrodt Llc	Functional, cross-linked nanostructures for tandem optical imaging and therapy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ200429A (en) *	1981-04-30	1984-10-19	Smith & Nephew Ass	Applicator for placing pharmaceutically active agent in contact with moist surface,e.g.,eye
US5140048A (en) *	1984-03-19	1992-08-18	The Rockefeller University	Inhibitors of nonenzymatic cross-linking
US5017696A (en) *	1987-09-17	1991-05-21	The Rockefeller University	Advanced glycosylation end products and associated methods
CA2042934C (en) *	1990-05-22	2002-04-23	Ryuji Ueno	Treatment of ocular hypertension with an ocular synergistic combination
NZ239161A (en) *	1990-07-31	1994-01-26	Smithkline Beecham Corp	Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
US5153205A (en) *	1990-10-01	1992-10-06	Merck & Co., Inc.	Method to reduce introacular pressure without causing miosis
US5300031A (en) *	1991-06-07	1994-04-05	Liebel-Flarsheim Company	Apparatus for injecting fluid into animals and disposable front loadable syringe therefor
FI119756B (en)	1995-01-18	2009-03-13	Alteon Inc	Use of Thiazolium Compounds to Prevent and Reverse Formation of Long-End Glycosylation
US5656261A (en)	1995-01-18	1997-08-12	The Picower Institute For Medical Research	Preventing and reversing advanced glycosylation endproducts
CN1142778C (en) *	1995-01-18	2004-03-24	奥尔顿有限公司	Use of thiazolium compounds for preventing and reversing the formation of advanced glycation end products
US5744451A (en) *	1995-09-12	1998-04-28	Warner-Lambert Company	N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US5854000A (en) *	1995-11-15	1998-12-29	Alteon Inc.	Methods for measurement predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
US6121300A (en) *	1998-11-10	2000-09-19	Wagle; Dilip R.	Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
EP1414464A4 (en) *	2001-05-30	2005-06-22	Alteon Inc	Method for treating glaucoma v
US6596745B2 (en) *	2001-05-30	2003-07-22	Alteon, Inc.	Method for treating fibrotic diseases with azolium chroman compounds
JP2004532249A (en) *	2001-05-30	2004-10-21	アルテオンインコーポレイテッド	Method for treating glaucoma VI

2001
- 2001-12-28 MX MXPA03005922A patent/MXPA03005922A/en active IP Right Grant
- 2001-12-28 DE DE60130030T patent/DE60130030T2/en not_active Expired - Fee Related
- 2001-12-28 AU AU2002241670A patent/AU2002241670B2/en not_active Ceased
- 2001-12-28 AT AT01988353T patent/ATE369856T1/en not_active IP Right Cessation
- 2001-12-28 EP EP01988353A patent/EP1353669B1/en not_active Expired - Lifetime
- 2001-12-28 JP JP2002554108A patent/JP2004520329A/en active Pending
- 2001-12-28 CA CA002433346A patent/CA2433346A1/en not_active Abandoned
- 2001-12-28 WO PCT/US2001/049550 patent/WO2002053158A1/en not_active Ceased
- 2001-12-31 US US10/038,112 patent/US7432254B2/en not_active Expired - Fee Related

Publication	Publication Date	Title
WO2002030487A8 (en)	2003-12-31	Methods for treating aneurysms
AU2001245522A1 (en)	2002-01-17	Apparatus and method for treating glaucoma
AU2001219185A1 (en)	2001-10-03	2-acylaminobenzimidazole derivatives for treating glaucoma
EP1414464A4 (en)	2005-06-22	Method for treating glaucoma v
AU2001269799A1 (en)	2002-04-02	Methods for treating various eye disorders
AU2002215125A1 (en)	2002-05-27	Well treatment method
AU2001231104A1 (en)	2001-08-07	Methods for treating diabetes
AU2651701A (en)	2001-07-24	Method for introducing additives
AU2002225930A1 (en)	2002-08-19	Methods for treating phosphatide-containing mixtures
AU2016701A (en)	2002-01-02	Secure communications method
AUPR617901A0 (en)	2001-08-02	Method for treating multiple myeloma
AU2001237939A1 (en)	2001-08-20	Methods for treating glaucoma
AU2042301A (en)	2001-06-12	1-aminoalkyl-1H-indoles for treating glaucoma
AUPR152100A0 (en)	2000-12-14	Method for treating coral
AU2002241670A1 (en)	2003-01-23	Method for treating glaucoma IB
EP1358225B8 (en)	2005-09-21	Method for treating emulsion polymers
AU2001277938A1 (en)	2002-02-05	Method for treating angina
AU2002214487A1 (en)	2002-05-21	Method for inducing apoptiosis
AU2002326991A1 (en)	2003-04-01	Methods for treating multiple sclerosis
AU1603401A (en)	2001-10-03	Pyranoindoles for treating glaucoma
AU2001237530A1 (en)	2001-08-27	Method
AU2001243297A1 (en)	2001-09-12	Method for treating or preventing depression
AU2001241636A1 (en)	2001-09-03	Halotherapy method
AU2002241687A1 (en)	2002-07-16	Method for treating glaucoma ii b
HK1051979A (en)	2003-08-29	Methods for treating glaucoma